The most interesting part of the $NRED news is not just MetalCore It’s the combination of AI, robotics, automation and new leadership all moving in the same direction That gives the company a chance to become a broader mining-tech platform $NREDF

$NRED is making a major strategic shift. Instead of focusing mainly on one mining project, the company is redirecting resources toward MetalCore, AI-driven mineral exploration, and mining robotics. That robotics angle could matter more than people realize. Mining is moving toward autonomous drilling, robotic inspection, computer vision, LiDAR mapping, remote equipment and AI systems that can work in places that are dangerous, expensive or difficult for people to access. If NRED can combine MetalCore’s geological intelligence with robotics and automation, the bigger opportunity is not just finding mineral targets. It’s building technology that could help mining companies decide where to explore, how to inspect sites, and eventually how to operate more efficiently with less human exposure to hazardous environments. That is a much broader story than a single copper-gold property. AI + mining data + robotics is the new direction.

$RYET +4.65% (price: $0.9199). Rising to the $1 level represents a gain of approximately 8.7%. For a $30,000 position, this implies a potential additional profit of around $2,610 if the price hits $1 Let's go-I'm still holding $INTC $MU $SMCI $ARM $QCOM $ORCL

The bigger picture behind the latest $RYET news is much larger than one Malaysia agreement AI in healthcare is becoming a global industry. Current market estimates put the sector at roughly $56B in 2026, with forecasts reaching around $1 TRILLION by 2034. That is the market backdrop for RYET latest move. Ruanyun announced a definitive agreement involving Cogni AI and BioNexus Gene Lab in Malaysia, giving its AI technology a path into healthcare rather than keeping it limited to education and enterprise applications. The structure is interesting too: an exclusive license framework of up to 20 years, 10% royalty economics on qualifying technology receipts, and 560K BGLC shares at closing. For me, this is what makes the news important. RYET is not suddenly becoming a healthcare giant. It is testing whether Cogni AI can be licensed into a completely different industry and international market while that industry itself is experiencing massive AI adoption. Education was the starting point. Enterprise AI expanded the story. Now healthcare adds another potential use case. If Cogni AI can continue moving across industries and markets, that becomes a much more interesting business model than relying on one product or one sector. Malaysia may be only the first healthcare test, but it puts RYET directly in front of one of the fastest-growing global technology trends.

$RYET just opened a new growth lane The company is moving into Malaysian healthcare through an exclusive agreement, adding another vertical to its international expansion story. AI. Education. Smart Campus. Now healthcare. Malaysia is becoming a much bigger part of the $RYET story

BREAKING: $RYET is entering Malaysian healthcare New Cogni AI deal with BioNexus includes an exclusive license for up to 20 years, 10% royalty economics and 560K BGLC shares at closing. New vertical. New market. Bigger global story

Most traders don’t miss moves because they can’t read a chart They miss them because the important update hits before they even know where to look $PLTR $RYET $OPEN $AMD Daily Market Memo filters the noise and sends the stories worth opening straight to your inbox Free access: dailymarketmemo.com/email

Traders watching $NVDA $PLTR $MSFT $RYET and the broader market: Join the Daily Market Memo Discord for breaking market updates, fresh catalysts, chart discussion and new ideas to research No guaranteed calls. No hype promises. Just traders comparing notes and following the market together Join here: dailymarketmemo.com/discord

six-month revenue could top FY2026 full-year revenue. Growth in focus $RYET. $AMD $PLTR

One number changes the $RYET story today: $9.3M-$9.5M That’s expected H1 FY2027 revenue - versus only ~$0.37M in H1 FY2026 And it already tops the company’s $7.48M FY2026 full-year revenue This is the revenue update traders should be watching

$RYET is getting easier to understand $7.48M FY2026 revenue, +11.9% YoY, plus an ~$880K YeeZo deployment across 10 AIGC labs and 610 workstations Now the focus is on what comes next: more paid deployments and more commercial growth

The biggest number in the $RYET story today is $9.3M-$9.5M That is expected preliminary H1 FY2027 revenue, compared with only about $0.37M in H1 FY2026 The business is operating at a completely different scale now $OPEN $QQQ

$RYET just delivered a revenue update that is difficult to ignore Preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M, compared with about $0.37M in H1 FY2026 and $4.11M in H1 FY2025 Even more notable: six months of FY2027 could already exceed the company’s entire FY2026 revenue of $7.48M Smart Campus is expected to contribute $5.0M-$5.2M Preliminary and unaudited, but the scale-up is significant

$RYET is getting easier to understand $7.48M FY2026 revenue, +11.9% YoY, plus an ~$880K YeeZo deployment across 10 AIGC labs and 610 workstations Now the focus is on what comes next: more paid deployments and more commercial growth

$RYET right now right here, you need to marvel at the new cool catalyst, it will cost more than $2 $AMD $PLTR $NFLX $AVGO